POM Investment Strategies’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$704 Sell
52
-50
-49% -$598 ﹤0.01% 339
2026
Q1
$611 Buy
102
+72
+240% +$542 ﹤0.01% 423
2025
Q4
$215 Buy
30
+23
+329% +$182 ﹤0.01% 329
2025
Q3
$75 Buy
7
+5
+250% +$49 ﹤0.01% 199
2025
Q2
$19 Hold
2
﹤0.01% 138
2025
Q1
$30 Hold
2
﹤0.01% 210
2024
Q4
$30 Hold
2
﹤0.01% 339
2024
Q3
$38 Hold
2
﹤0.01% 310
2024
Q2
$41 Hold
2
﹤0.01% 321
2024
Q1
$38 Buy
+2
New +$34 ﹤0.01% 249

Other funds holding OGN

POM Investment Strategies's OGN Position: Q2 2026 in Review

POM Investment Strategies reduced its Organon & Co (OGN) stake by 49% in Q2 2026, selling an estimated $598 and leaving 52 shares worth $704. The position accounts for ﹤0.01% of the portfolio, ranked #339.

POM Investment Strategies first reported a position in OGN in Q1 2024 and has held it in 10 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • POM Investment Strategies held 52 shares of Organon & Co worth $704 as of Q2 2026.
  • POM Investment Strategies sold 50 Organon & Co shares in Q2 2026, an estimated $598.
  • Organon & Co made up ﹤0.01% of POM Investment Strategies's portfolio in Q2 2026, its #339 holding.
  • POM Investment Strategies first reported a position in Organon & Co in Q1 2024 and has held it in 10 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on POM Investment Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.